The peritoneal-plasma barrier retards the clearance of high molecular weight chemotherapy from the peritoneal cavity and allows a large exposure of small residual cancer nodules.
From a pharmacological point of view, this is an attractive approach given the peritoneal-plasma barrier, which allows for higher peritoneal cavity concentrations resulting in higher efficacy while systemic toxicity is not increased.
Hence, we investigate a self-aligned double pocket charge plasma Schottky barrier tunnel FET (CP-SB-TFET).
When the plasma deposited barrier becomes 300 nm thick, the hydrolysis curve of the enzyme presents a lag phase typical of a diffusion-limited process.
Thin plasma polymerized barrier films are deposited on Nafion® membranes in a low pressure microwave generated plasma to reduce their methanol permeability.
The diffusion of the chromophore to the outside surface of the undoped layer was examined with and without the plasma polymerized barrier layer.
This work deals with surface modification of aluminium alloy AA7075 by two types of atmospheric pressure plasma: dielectric barrier discharge (DBD) and atmospheric pressure plasma jet (APPJ) with the purpose to enhance the adhesion of polyurethane coating on the alloy.
The delivery of active molecules into cells requires the step of efficiently cross the plasma membrane barrier.
This test performs a colorimetric determination of the capacity of the plasma antioxidant barrier to cope with oxidation by the hypochlorous acid (HClO).
Optimisation of influx, across the plasma membrane barrier of target cells, would therefore increase the therapeutic efficacy of a drug.
This might be explained as an effort to compensate high ATP consumption rates due to malfunction of the plasma membrane barrier or poor performance of ATP synthesis.
